Association of empathy with clinical symptoms and cognitive function in Chinese chronic schizophrenia patients with and without deficit syndrome

Junyao Liu,Yang Tian,Shuochi Wei,Wenjia Wang,Dongmei Wang,Huixia Zhou,Xiangyang Zhang
DOI: https://doi.org/10.1016/j.pnpbp.2022.110592
2022-06-17
Abstract:Background Patients with deficit syndrome (DS) are known to experience cognitive impairment. However, there is no consistent conclusion on the impairment of neurocognitive features in DS patients, and no studies have examined their empathy. The purpose of this study was to compare neurocognition and empathy in patients with DS and non-DS schizophrenia. Methods Totally, 665 patients with chronic schizophrenia were enrolled. DS patients were identified by the Proxy Scale for Deficit Syndrome (PDS). Neurocognition and social cognition were assessed by Repeatable Battery for the measurement of Neuropsychological Status (RBANS) and the Interpersonal Reactivity Index (IRI), respectively. In addition, psychopathological symptoms severity was assessed by the Positive and Negative Syndrome Scale (PANSS). Results Participants included 150 patients with DS and 140 patients with non-DS. DS patients performed significantly worse on the all RBANS domain (except for visuospatial) and total scores as well as IRI scores. Regression results showed that PANSS general psychopathology and education were associated with RBANS total score in the DS group (adjusted R 2 = 0.29), while education and PANSS negative symptoms were correlated with RBANS total score in non-DS patients (adjusted R 2 = 0.33). In the non-DS group, suicide and PANSS negative symptom factor scores were independently associated with IRI total score (adjusted R 2 = 0.06), whereas in the DS group, no variable was associated with IRI total score. Conclusions Our findings suggest that patients with DS may have poor neurocognitive and empathy performance. In chronic schizophrenia patients, negative symptoms may play a different role in cognition between DS and non-DS groups.
pharmacology & pharmacy,neurosciences,psychiatry,clinical neurology
What problem does this paper attempt to address?